The Trump administration has signaled it's behind the psychedelic renaissance, but there are still big questions about how these drugs will be administered once they are approved by the FDA.
Copyright 2026 NPR
The Trump administration has signaled it's behind the psychedelic renaissance, but there are still big questions about how these drugs will be administered once they are approved by the FDA.
Copyright 2026 NPR
NHPR is nonprofit and independent. We rely on readers like you to support the local, national, and international coverage on this website. Your support makes this news available to everyone.
Give today. A monthly donation of $5 makes a real difference.